To the best of our knowledge, our study is the first to compare the effects of adding fenofibrate versus curcumin on glimepiride therapy on weight, glycemic status, lipid profile, hs-CRP, fetuin-A, and sirtuin 1 in patients with type 2 diabetes. The gene discussed is AHSG; the disease is type 2 diabetes mellitus.